Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I James

Showing results (261-270 of 300) with videos related to

Pageof 30
Sort By:
ACS Chemical Biology|August 20, 2021
A Peptidomimetic Ligand Targeting the Chromodomain of MPP8 Reveals HRP2's Association with the HUSH ComplexJarod M Waybright, Sarah E Clinkscales, Kimberly D Barnash, et al.
Nature Communications|April 23, 2026
Structural basis of NSD2 degradation via targeted recruitment of SCF-FBXO22Kevin C Robertson, Sascha J Amann, Tongkun Liu, et al.
European Heart Journal|July 2, 2025
Carbon emission analysis of aortic valve replacement: the environmental footprint of transcatheter vs. surgical proceduresDavid Blitzer, Christoph J Meinrenken, Nora Bystadhaugen Apelgren, et al.
Cancer Cell|March 20, 2019
DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase InhibitorsNisha Pillay, Anthony Tighe, Louisa Nelson, et al.
ACS Bio & Med Chem Au|April 20, 2026
Discovery of Small-Molecule Antagonists of PHF1 and 19 Demonstrates the Ligandability of PRC2 Accessory ProteinsIsabelle E Amick, Rebecca L Johnson, Jiuyang Liu, et al.
Frontiers in Oncology|February 16, 2023
MS0621, a novel small-molecule modulator of Ewing sarcoma chromatin accessibility, interacts with an RNA-associated macromolecular complex and influences RNA splicingTamara Vital, Aminah Wali, Kyle V Butler, et al.
Cancer Letters|May 17, 2015
Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapyMark I James, Chinenye Iwuji, Glen Irving, et al.
Science (New York, N.Y.)|October 12, 2019
NextGen advises "Trying to Manage"Douglas Steinhauff, Joel Henrique Ellwanger, Monika Lewinska, et al.
ACS Chemical Biology|January 16, 2015
Identification of a fragment-like small molecule ligand for the methyl-lysine binding protein, 53BP1Michael T Perfetti, Brandi M Baughman, Bradley M Dickson, et al.
ACS Chemical Biology|October 1, 2016
First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to OlaparibDominic I James, Kate M Smith, Allan M Jordan, et al.
Pageof 30

Showing results (261-270 of 300) with videos related to

Sort By:
Pageof 30
ACS Chemical Biology|August 20, 2021
A Peptidomimetic Ligand Targeting the Chromodomain of MPP8 Reveals HRP2's Association with the HUSH ComplexJarod M Waybright, Sarah E Clinkscales, Kimberly D Barnash, et al.
Nature Communications|April 23, 2026
Structural basis of NSD2 degradation via targeted recruitment of SCF-FBXO22Kevin C Robertson, Sascha J Amann, Tongkun Liu, et al.
European Heart Journal|July 2, 2025
Carbon emission analysis of aortic valve replacement: the environmental footprint of transcatheter vs. surgical proceduresDavid Blitzer, Christoph J Meinrenken, Nora Bystadhaugen Apelgren, et al.
Cancer Cell|March 20, 2019
DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase InhibitorsNisha Pillay, Anthony Tighe, Louisa Nelson, et al.
ACS Bio & Med Chem Au|April 20, 2026
Discovery of Small-Molecule Antagonists of PHF1 and 19 Demonstrates the Ligandability of PRC2 Accessory ProteinsIsabelle E Amick, Rebecca L Johnson, Jiuyang Liu, et al.
Frontiers in Oncology|February 16, 2023
MS0621, a novel small-molecule modulator of Ewing sarcoma chromatin accessibility, interacts with an RNA-associated macromolecular complex and influences RNA splicingTamara Vital, Aminah Wali, Kyle V Butler, et al.
Cancer Letters|May 17, 2015
Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapyMark I James, Chinenye Iwuji, Glen Irving, et al.
Science (New York, N.Y.)|October 12, 2019
NextGen advises "Trying to Manage"Douglas Steinhauff, Joel Henrique Ellwanger, Monika Lewinska, et al.
ACS Chemical Biology|January 16, 2015
Identification of a fragment-like small molecule ligand for the methyl-lysine binding protein, 53BP1Michael T Perfetti, Brandi M Baughman, Bradley M Dickson, et al.
ACS Chemical Biology|October 1, 2016
First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to OlaparibDominic I James, Kate M Smith, Allan M Jordan, et al.
Pageof 30